254 related articles for article (PubMed ID: 23609999)
1. Development and validation of a new disease activity score in 28 joints-based treatment response criterion for rheumatoid arthritis.
Behrens F; Tony HP; Alten R; Kleinert S; Scharbatke EC; Köhm M; Gnann H; Tams J; Greger G; Burkhardt H
Arthritis Care Res (Hoboken); 2013 Oct; 65(10):1608-16. PubMed ID: 23609999
[TBL] [Abstract][Full Text] [Related]
2. Is swollen to tender joint count ratio a new and useful clinical marker for biologic drug response in rheumatoid arthritis? Results from a Swedish cohort.
Kristensen LE; Bliddal H; Christensen R; Karlsson JA; Gülfe A; Saxne T; Geborek P
Arthritis Care Res (Hoboken); 2014 Feb; 66(2):173-9. PubMed ID: 23982986
[TBL] [Abstract][Full Text] [Related]
3. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a patient-based disease activity score in rheumatoid arthritis that can be used in clinical trials and routine practice.
Choy EH; Khoshaba B; Cooper D; MacGregor A; Scott DL
Arthritis Rheum; 2008 Feb; 59(2):192-9. PubMed ID: 18240256
[TBL] [Abstract][Full Text] [Related]
5. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis.
Welsing PM; Fransen J; van Riel PL
Arthritis Rheum; 2005 Sep; 52(9):2616-24. PubMed ID: 16142762
[TBL] [Abstract][Full Text] [Related]
6. Efficient management of rheumatoid arthritis significantly reduces long-term functional disability.
Tanaka E; Mannalithara A; Inoue E; Hara M; Tomatsu T; Kamatani N; Singh G; Yamanaka H
Ann Rheum Dis; 2008 Aug; 67(8):1153-8. PubMed ID: 17971459
[TBL] [Abstract][Full Text] [Related]
7. American College of Rheumatology/European League Against Rheumatism remission criteria for rheumatoid arthritis maintain reliable performance when evaluated in 44 joints.
Kaneko Y; Kondo H; Takeuchi T
J Rheumatol; 2013 Aug; 40(8):1254-8. PubMed ID: 23772077
[TBL] [Abstract][Full Text] [Related]
8. Association of Improvement in Pain With Therapeutic Response as Determined by Individual Improvement Criteria in Patients With Rheumatoid Arthritis.
Scharbatke EC; Behrens F; Schmalzing M; Koehm M; Greger G; Gnann H; Burkhardt H; Tony HP
Arthritis Care Res (Hoboken); 2016 Nov; 68(11):1607-1615. PubMed ID: 26990995
[TBL] [Abstract][Full Text] [Related]
9. Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry.
Hetland ML; Christensen IJ; Tarp U; Dreyer L; Hansen A; Hansen IT; Kollerup G; Linde L; Lindegaard HM; Poulsen UE; Schlemmer A; Jensen DV; Jensen S; Hostenkamp G; Østergaard M;
Arthritis Rheum; 2010 Jan; 62(1):22-32. PubMed ID: 20039405
[TBL] [Abstract][Full Text] [Related]
10. Individual therapeutic DAS28-d
Koehm M; McIntosh MJ; Hofmann MW; Abraham V; Gabay C; Choy EH; Kavanaugh A; Burkhardt H; Behrens F
Rheumatol Int; 2020 May; 40(5):747-755. PubMed ID: 32040761
[TBL] [Abstract][Full Text] [Related]
11. Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activity.
Tymms K; Zochling J; Scott J; Bird P; Burnet S; de Jager J; Griffiths H; Nicholls D; Roberts L; Arnold M; Littlejohn G
Arthritis Care Res (Hoboken); 2014 Feb; 66(2):190-6. PubMed ID: 23983001
[TBL] [Abstract][Full Text] [Related]
12. Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints.
Aletaha D; Smolen JS
Arthritis Rheum; 2011 Dec; 63(12):3702-11. PubMed ID: 21953215
[TBL] [Abstract][Full Text] [Related]
13. Can remission in rheumatoid arthritis be assessed without laboratory tests or a formal joint count? possible remission criteria based on a self-report RAPID3 score and careful joint examination in the ESPOIR cohort.
Castrejón I; Dougados M; Combe B; Guillemin F; Fautrel B; Pincus T
J Rheumatol; 2013 Apr; 40(4):386-93. PubMed ID: 23378463
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of patients with rheumatoid arthritis in Qatar: a cross-sectional study.
Lutf A; Poil AR; Hammoudeh M
Int J Rheum Dis; 2014 Jan; 17(1):63-5. PubMed ID: 24472269
[TBL] [Abstract][Full Text] [Related]
15. Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.
Wechalekar MD; Lester S; Proudman SM; Cleland LG; Whittle SL; Rischmueller M; Hill CL
Arthritis Rheum; 2012 May; 64(5):1316-22. PubMed ID: 22135142
[TBL] [Abstract][Full Text] [Related]
16. The impact of prior biologic therapy on adalimumab response in patients with rheumatoid arthritis.
Feuchtenberger M; Kleinert S; Scharbatke EC; Gnann H; Behrens F; Wittig BM; Greger G; Tony HP
Clin Exp Rheumatol; 2015; 33(3):321-9. PubMed ID: 25897681
[TBL] [Abstract][Full Text] [Related]
17. Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study.
Vermeer M; Kuper HH; Hoekstra M; Haagsma CJ; Posthumus MD; Brus HL; van Riel PL; van de Laar MA
Arthritis Rheum; 2011 Oct; 63(10):2865-72. PubMed ID: 21647867
[TBL] [Abstract][Full Text] [Related]
18. Patient-derived joint counts are a potential alternative for determining Disease Activity Score.
Kavanaugh A; Lee SJ; Weng HH; Chon Y; Huang XY; Lin SL
J Rheumatol; 2010 May; 37(5):1035-41. PubMed ID: 20156946
[TBL] [Abstract][Full Text] [Related]
19. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
20. The effect of different remission definitions on identification of predictors of both point and sustained remission in rheumatoid arthritis treated with anti-TNF therapy.
Barnabe C; Homik J; Barr SG; Martin L; Maksymowych WP
J Rheumatol; 2014 Aug; 41(8):1607-13. PubMed ID: 25028371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]